Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 4/2023

30-03-2023 | Obesity | Correction

Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

Authors: Karlyn A Martin, Nicola Lancki, Celina Li, M. Elaine Eyster, Kristen Sanfilippo, Isabela A. Woller, Scott C. Woller, Lisa Baumann Kreuziger, Rachel P. Rosovsky

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2023

Login to get access

Excerpt

Journal of Thrombosis and Thrombolysis …
Metadata
Title
Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network
Authors
Karlyn A Martin
Nicola Lancki
Celina Li
M. Elaine Eyster
Kristen Sanfilippo
Isabela A. Woller
Scott C. Woller
Lisa Baumann Kreuziger
Rachel P. Rosovsky
Publication date
30-03-2023
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2023
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-023-02803-z

Other articles of this Issue 4/2023

Journal of Thrombosis and Thrombolysis 4/2023 Go to the issue

OriginalPaper

Effects of uridine and nucleotides on hemostasis parameters

OriginalPaper

Management and outcomes of women with antiphospholipid syndrome during pregnancy

ReviewPaper

A scoping review of direct oral anticoagulant ambulatory management practices

OriginalPaper

An exploratory study of effectiveness and safety of rivaroxaban in patients with left ventricular thrombus (R-DISSOLVE)

Editorial

Evaluating chest pain in patients with post COVID conditions permission to think outside of the box

Letter to the Editor

Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits